Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a new version of the page content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.4 is now shown on the page, replacing Revision: v3.6.3, indicating an updated version of the page. This change appears to be a metadata/version update rather than a substantive alteration to study data or content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This reflects a minor refresh of the page template or content rendering.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This change updates the page version without altering the displayed study details.SummaryDifference0.1%

- Check66 days agoChange DetectedRecruitment status changed to closed with added guidance sections for joining and reading the study, and the Intervention/Treatment heading and revision label were updated to reflect the latest structure (v3.6.0).SummaryDifference0.5%

- Check73 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, indicating a minor internal update to the study record. This change reflects version control rather than content changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.